title: Response to lenalidomide of a patient with t(2;3)(p23;q29) and JAK2 non-mutated refractory anemia with ring sideroblasts and thrombocytosis.
authors.forename: Min
authors.initials: M
authors.lastname: Zhang
authors.forename: Yong
authors.initials: Y
authors.lastname: You
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Li
authors.forename: Yanli
authors.initials: Y
authors.lastname: He
authors.forename: Jine
authors.initials: J
authors.lastname: Zheng
authors.forename: Weiming
authors.initials: W
authors.lastname: Li
authors.forename: Ping
authors.initials: P
authors.lastname: Zou
authors.forename: Xinyue
authors.initials: X
authors.lastname: Liu
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
mesh_terms: D000328:Adult; D000753:Anemia, Refractory / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D001853:Bone Marrow / Q000473:pathology; D002889:Chromosomes, Human, Pair 2; D002893:Chromosomes, Human, Pair 3; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D059785:Karyotype; D000077269:Lenalidomide; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013922:Thrombocytosis / Q000150:complications; D014178:Translocation, Genetic; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D053614:Janus Kinase 2; D000077269:Lenalidomide